mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
AZD0530 |
FIMM |
pan-cancer |
AAC |
-0.067 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |